Medlab IP Pty Ltd – Trademark Portfolio
Entity Type: 99
Medlab IP Pty Ltd holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 13 filings in this category. The portfolio also extends into Class 29 (Meats & Processed Foods) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include NRGBIOTIC.
66 McCauley St
Alexandria NSW 2015
Showing of trademarks Trademarks
Trademark Classifications
Medlab IP Pty Ltd's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Frequently Asked Questions
How many trademarks does Medlab IP Pty Ltd have?
Medlab IP Pty Ltd has 15 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 4 cancelled.
What trademark classes does Medlab IP Pty Ltd file in?
Medlab IP Pty Ltd files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 9 (Computers & Electronics), Class 16 (Paper Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Medlab IP Pty Ltd's most well-known trademarks?
Medlab IP Pty Ltd's registered trademark portfolio includes well-known marks such as NRGBIOTIC. These are among 1 currently registered trademark in the portfolio.
What is Medlab IP Pty Ltd's trademark registration success rate?
Medlab IP Pty Ltd has a 7% trademark registration rate, with 1 out of 14 resolved applications resulting in successful registration. Currently, 0 applications are pending review.